Jelmyto savings card: as little as $50 a dose with commercial insurance

How to pay the least

Ask for the cash price

Jelmyto

The FDA has approved a generic, but it isn’t in pharmacies yet.

Ask your pharmacy for Jelmyto’s cash price, and one or two other pharmacies too.
Jelmyto’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameJelmyto

Authorized genericmitomycin

Regular genericmitomycin

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNot in stores yet

Same as Jelmyto?

The original

–

Brand nameThe maker’s card

UroGen Support Copay Program

Savings card from UroGen Pharma

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $50 a dose

The card takes up to $14,000 a year off your co-pay.

Or call 1-888-793-9355.

In the maker’s words

“You may qualify for the UroGen SupportTM Copay Program. If you are eligible, you will pay as little as $50 for each dose of Jelmyto with a maximum benefit of up to $14,000 per year.”

From the maker’s offer on jelmyto.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Jelmyto itself, from the same company, sold without the brand name, and usually for less. For now Jelmyto is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

The FDA has approved a generic, but it isn’t in pharmacies yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Upper urinary tract cancer (low-grade UTUC)

What the FDA label says

JELMYTO is an alkylating drug indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC).

Source: the FDA label for Jelmyto (UroGen Pharma, Inc.), July 9, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/jelmyto/